Abstract | INTRODUCTION:
Heparin is often prescribed during pregnancy with the intention of improving perinatal outcomes on the basis that it exerts an anticoagulant action in the inter-villous space. Accumulating in-vitro and in-vivo evidence indicates that heparin's beneficial effects in pregnancy may result from 'non- anticoagulant' effects including the promotion of angiogenesis. METHODS: To study the effect of heparin within the placenta, we performed secondary analyses on a pilot trial where 32 women with negative thrombophilia screens and second-trimester evidence of placental insufficiency were randomized to standard care or antenatal self-administration of unfractionated heparin (UFH) 7500 IU twice-daily. Serial placental ultrasound images were reviewed and compared with histo-pathologic findings following delivery. RESULTS: There were no differences between the two arms in either the evolution of abnormal placental lesions on ultrasound (p = 0.75) or evidence of maternal vascular under-perfusion on histopathology (p = 0.89). In pregnancies considered at increased risk for adverse pregnancy outcomes based on previous history or abnormal serum marker screen, early (second-trimester) placental ultrasound, reflecting developmental pathology had better test characteristics (sensitivity 77.8%; positive predictive value 80.8%) for predicting adverse pregnancy outcomes than third-trimester ultrasound that is reflective of placental thrombotic injury. CONCLUSIONS: Administration of UFH did not prevent the development or evolution of abnormal placental lesions on placental ultrasound or evidence of maternal vascular underperfusion on placental histo-pathology. Second-trimester placental ultrasound may be of value in predicting those at greatest risk of adverse outcomes.
|
Authors | R D'Souza, S Keating, M Walker, S Drewlo, J Kingdom |
Journal | Placenta
(Placenta)
Vol. 35
Issue 10
Pg. 816-23
(Oct 2014)
ISSN: 1532-3102 [Electronic] Netherlands |
PMID | 25128485
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Crown Copyright © 2014. Published by Elsevier Ltd. All rights reserved. |
Chemical References |
|
Topics |
- Adult
- Female
- Heparin
(pharmacology, therapeutic use)
- Humans
- Pilot Projects
- Placenta
(diagnostic imaging, drug effects, pathology)
- Placental Insufficiency
(diagnostic imaging, drug therapy, pathology)
- Pregnancy
- Pregnancy Outcome
- Pregnancy Trimester, Second
- Pregnancy, High-Risk
- Treatment Outcome
- Ultrasonography, Prenatal
|